• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

醋酸钙给药时间对磷结合的影响。

Effect of the time of administration of calcium acetate on phosphorus binding.

作者信息

Schiller L R, Santa Ana C A, Sheikh M S, Emmett M, Fordtran J S

机构信息

Department of Internal Medicine, Baylor University Medical Center, Dallas, TX 75246.

出版信息

N Engl J Med. 1989 Apr 27;320(17):1110-3. doi: 10.1056/NEJM198904273201703.

DOI:10.1056/NEJM198904273201703
PMID:2710173
Abstract

Phosphorus binders are given to patients with renal failure to increase gastrointestinal excretion of phosphorus. To determine the relative importance of the binding of dietary as compared with endogenous phosphorus and to determine the optimal dose schedule, we gave either 4.4 g of calcium acetate (25 mmol of calcium) or a placebo to six normal subjects on each of seven different schedules in a randomized sequence. The net gastrointestinal balance of phosphorus and calcium was determined by a one-day lavage technique. After a meal containing approximately 12 mmol of phosphorus, the mean phosphorus absorption (+/- SE) measured 9.17 +/- 0.36 mmol (78 percent) with placebo but decreased to 3.81 +/- 0.58 mmol (31 percent) when calcium acetate was given immediately before the meal (representing binding of 5.36 +/- 0.77 mmol of phosphorus). Similar binding was observed when calcium acetate was given immediately after the meal and when half the dose was given before and half after the meal. In contrast, when calcium acetate was given two hours after the meal or while the subject was fasting, phosphorus binding was reduced to 2.00 +/- 0.52 mmol and 1.81 +/- 0.84 mmol, respectively. Calcium absorption from calcium acetate averaged 21 +/- 1 percent when the binder was given with a meal; absorption from calcium acetate averaged 40 +/- 4 percent when the binder was given while the subject was fasting. We conclude that calcium acetate increases fecal excretion of phosphorus by binding both dietary and endogenous phosphorus, but the binding of dietary phosphorus is quantitatively much more important. For the most efficient phosphorus binding, calcium (and presumably other phosphorus-binding cations) should be given with meals.

摘要

给肾衰竭患者使用磷结合剂以增加胃肠道对磷的排泄。为了确定饮食中磷与内源性磷结合的相对重要性,并确定最佳给药方案,我们以随机顺序在七个不同方案中的每个方案下,给六名正常受试者分别服用4.4克醋酸钙(25毫摩尔钙)或安慰剂。通过一日灌洗技术测定磷和钙的胃肠道净平衡。在摄入含约12毫摩尔磷的一餐之后,服用安慰剂时测得的平均磷吸收量(±标准误)为9.17±0.36毫摩尔(78%),但在进餐前立即服用醋酸钙时降至3.81±0.58毫摩尔(31%)(相当于结合了5.36±0.77毫摩尔磷)。在餐后立即服用醋酸钙以及将剂量的一半在餐前服用、一半在餐后服用时,观察到了类似的结合情况。相比之下,当在餐后两小时或受试者禁食时服用醋酸钙,磷结合量分别降至2.00±0.52毫摩尔和1.81±0.84毫摩尔。当与餐同服结合剂时,醋酸钙的钙吸收平均为21±1%;当受试者禁食时服用结合剂,醋酸钙的钙吸收平均为40±4%。我们得出结论,醋酸钙通过结合饮食中的磷和内源性磷来增加粪便中磷的排泄,但饮食中磷的结合在数量上更为重要。为了最有效地结合磷,钙(可能还有其他磷结合阳离子)应与餐同服。

相似文献

1
Effect of the time of administration of calcium acetate on phosphorus binding.醋酸钙给药时间对磷结合的影响。
N Engl J Med. 1989 Apr 27;320(17):1110-3. doi: 10.1056/NEJM198904273201703.
2
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
3
Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.慢性间歇性血液透析患者中的氢氧化铝、碳酸钙和醋酸钙
Clin Nephrol. 1996 Feb;45(2):111-9.
4
Calcium acetate versus calcium carbonate as phosphorus binders in patients on chronic haemodialysis: a controlled study.醋酸钙与碳酸钙作为慢性血液透析患者磷结合剂的对照研究。
Nephrol Dial Transplant. 1993;8(4):341-6.
5
Gastrointestinal absorption of calcium from milk and calcium salts.牛奶及钙盐中钙的胃肠道吸收
N Engl J Med. 1987 Aug 27;317(9):532-6. doi: 10.1056/NEJM198708273170903.
6
Calcium acetate, an effective phosphorus binder in patients with renal failure.
Kidney Int. 1989 Oct;36(4):690-5. doi: 10.1038/ki.1989.247.
7
Calcium and phosphorus metabolism in nephrotic syndrome.肾病综合征中的钙磷代谢
Q J Med. 1977 Jul;46(183):327-38.
8
Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate.用碳酸氢钾治疗的绝经后妇女矿物质平衡和骨骼代谢得到改善。
N Engl J Med. 1994 Jun 23;330(25):1776-81. doi: 10.1056/NEJM199406233302502.
9
Sevelamer reduces calcium load and maintains a low calcium-phosphorus ion product in dialysis patients.司维拉姆可降低透析患者的钙负荷并维持低钙磷离子乘积。
J Nephrol. 2001 May-Jun;14(3):176-83.
10
Calcium load during administration of calcium carbonate or sevelamer in individuals with normal renal function.在肾功能正常的个体中给予碳酸钙或司维拉姆期间的钙负荷。
Nephrol Dial Transplant. 2008 Sep;23(9):2861-7. doi: 10.1093/ndt/gfn151. Epub 2008 Apr 3.

引用本文的文献

1
Hypoparathyroidism: diagnosis, management and emerging therapies.甲状旁腺功能减退症:诊断、管理及新出现的治疗方法。
Nat Rev Endocrinol. 2025 Jun;21(6):360-374. doi: 10.1038/s41574-024-01075-8. Epub 2025 Feb 4.
2
Dietary calcium intake does not meet the nutritional requirements of children with chronic kidney disease and on dialysis.膳食钙摄入量不能满足患有慢性肾病且正在接受透析的儿童的营养需求。
Pediatr Nephrol. 2020 Oct;35(10):1915-1923. doi: 10.1007/s00467-020-04571-x. Epub 2020 May 8.
3
The dietary management of calcium and phosphate in children with CKD stages 2-5 and on dialysis-clinical practice recommendation from the Pediatric Renal Nutrition Taskforce.
儿童 CKD 2-5 期和透析患者的钙和磷饮食管理-儿科肾脏营养工作组的临床实践建议。
Pediatr Nephrol. 2020 Mar;35(3):501-518. doi: 10.1007/s00467-019-04370-z. Epub 2019 Oct 30.
4
Nicotinic Acid as a Phosphate-lowering Agent in Patients with End-stage Renal Disease on Maintenance Hemodialysis: A Single-center Prospective Study.烟酸作为维持性血液透析的终末期肾病患者的降磷药物:一项单中心前瞻性研究
Cureus. 2019 Apr 30;11(4):e4566. doi: 10.7759/cureus.4566.
5
Intraperitoneal delivery of acetate-encapsulated liposomal nanoparticles for neuroprotection of the penumbra in a rat model of ischemic stroke.醋酸盐包封脂质体纳米粒经腹腔给药对缺血性脑卒中大鼠模型半影区的神经保护作用。
Int J Nanomedicine. 2019 Mar 18;14:1979-1991. doi: 10.2147/IJN.S193965. eCollection 2019.
6
Phosphate binders in patients with chronic kidney disease.慢性肾脏病患者的磷结合剂
Aust Prescr. 2017 Feb;40(1):10-14. doi: 10.18773/austprescr.2017.002. Epub 2017 Feb 1.
7
Contribution of food additives to sodium and phosphorus content of diets rich in processed foods.食品添加剂对富含加工食品的饮食中钠和磷含量的贡献。
J Ren Nutr. 2014 Jan;24(1):13-9, 19e1. doi: 10.1053/j.jrn.2013.09.003.
8
Association of a reduction in central obesity and phosphorus intake with changes in urinary albumin excretion: the PREMIER study.中心性肥胖减少和磷摄入与尿白蛋白排泄变化的关联:PREMIER 研究。
Am J Kidney Dis. 2013 Nov;62(5):900-7. doi: 10.1053/j.ajkd.2013.04.022. Epub 2013 Jun 28.
9
Hypercalcemia, metabolic alkalosis and renal failure secondary to calcium bicarbonate intake for osteoporosis prevention--'modern' milk alkali syndrome: a case report.因预防骨质疏松摄入碳酸氢钙继发高钙血症、代谢性碱中毒和肾衰竭——“现代”乳碱综合征:一例报告
Cases J. 2009 Aug 6;2:6188. doi: 10.4076/1757-1626-2-6188.
10
Treatment options for hyperphosphatemia in feline CKD: what's out there?猫慢性肾病高磷血症的治疗选择:有哪些方法?
J Feline Med Surg. 2009 Nov;11(11):913-24. doi: 10.1016/j.jfms.2009.09.012.